Arrow Capital Management, LLC

Q4 2013 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
12/31/2013
Date filed
2/14/2014
Form type
13F-HR
Num holdings
15
Total value ($000)
$140,203
Net value change ($000)
New positions
14
Sold out positions
0
Turnover %
100.0%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to previous filing: —
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
HRB 21,257
Bausch Health 21,191
CRI 20,665
MA 14,693
ENDO PHARMACEUTICALS HLDGS 11,940
LBTYA 10,919
MCGRAW HILL COS 10,557
CHARTER COMMUNICATIO 9,095
W R GRACE & CO 5,833
TDG 4,831
Top Reduces (Value $000, Stocks/ETFs)
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 2,904 (2.1% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None